
X
No new patients should take Lilly’s cancer drug Lartruvo, say regulators
https://pharmaphorum.com/news/no-new-patients-should-take-lillys-cancer-drug-lartruvo-say-regulators/
Lilly’s drug will be re-appraised in 2020
Regulators conditionally back Lartruvo, based on mid-stage data.